BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2642711)

  • 21. Proton magnetic resonance study of Streptomyces subtilisin inhibitor. pH titration and assignments of individual tyrosyl resonances.
    Fujii S; Akasaka K; Hatano H
    Biochemistry; 1981 Feb; 20(3):518-23. PubMed ID: 7011365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin.
    Jørgensen AM; Olsen HB; Balschmidt P; Led JJ
    J Mol Biol; 1996 Apr; 257(3):684-99. PubMed ID: 8648633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The aromatic residues of bovine pancreatic ribonuclease studied by 1H nuclear magnetic resonance.
    Lenstra JA; Bolscher BG; Beintema JJ; Kaptein R
    Eur J Biochem; 1979 Aug; 98(2):385-97. PubMed ID: 39752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of the B16 and B26 tyrosine residues to the biological activity of insulin.
    Hu SQ; Burke GT; Katsoyannis PG
    J Protein Chem; 1993 Dec; 12(6):741-7. PubMed ID: 8136024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectra of adrenodoxin: features of the aromatic region.
    Greenfield NJ; Wu XH; Jordan F
    Biochim Biophys Acta; 1989 May; 995(3):246-54. PubMed ID: 2706273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1H NMR studies on bovine cyclophilin: preliminary structural characterization of its complex with cyclosporin A.
    Heald SL; Harding MW; Handschumacher RE; Armitage IM
    Biochemistry; 1990 May; 29(18):4466-78. PubMed ID: 2190633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shortened insulin with enhanced in vitro potency.
    Casaretto M; Spoden M; Diaconescu C; Gattner HG; Zahn H; Brandenburg D; Wollmer A
    Biol Chem Hoppe Seyler; 1987 Jun; 368(6):709-16. PubMed ID: 3304338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 500-MHz 1H NMR studies of ragweed allergen Ra5.
    Vidusek DA; Roberts MF; Goodfriend L
    Biochemistry; 1985 May; 24(11):2747-53. PubMed ID: 4027223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [B-chain shortening of matrix-bound insulin by pepsin, I:Preparation and properties of bovine des-pentapeptide(B26-30) insulin (suthor's transl)].
    Gattner HG
    Hoppe Seylers Z Physiol Chem; 1975 Sep; 356(9):1397-404. PubMed ID: 240771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
    Cara JF; Nakagawa SH; Tager HS
    Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward the solution structure of human insulin: sequential 2D 1H NMR assignment of a des-pentapeptide analogue and comparison with crystal structure.
    Hua QX; Weiss MA
    Biochemistry; 1990 Nov; 29(46):10545-55. PubMed ID: 2271664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton N.M.R. study of the conformational dynamics of porcine pancreatic colipase. Titration of aromatic residues.
    Canioni P; Cozzone PJ
    Biochimie; 1979; 61(3):343-54. PubMed ID: 454687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton nuclear magnetic resonance study of the B9(Asp) mutant of human insulin. Sequential assignment and secondary structure.
    Kristensen SM; Jørgensen AM; Led JJ; Balschmidt P; Hansen FB
    J Mol Biol; 1991 Mar; 218(1):221-31. PubMed ID: 2002506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton nuclear magnetic resonance characterization of the aromatic residues in the variant-3 neurotoxin from Centruroides sculpturatus Ewing.
    Krishna NR; Nettesheim DG; Klevit RE; Drobny G; Watt DD; Bugg CE
    Biochemistry; 1989 Feb; 28(4):1555-62. PubMed ID: 2719918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactive conformation of an insulin despite its wild-type sequence.
    Kurapkat G; De Wolf E; Grötzinger J; Wollmer A
    Protein Sci; 1997 Mar; 6(3):580-7. PubMed ID: 9070440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer.
    Zoete V; Meuwly M; Karplus M
    J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine.
    Du H; Shi J; Cui D; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):133-9. PubMed ID: 18235975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-chain shortening of matrix-bound insulin with pepsin, II. Preparation and properties of camel des-pentapeptide (B26-30)- and des-PheB1-des-pentapeptide (B26-30)- insulin.
    Danho WO; Gattner HG; Nissen D; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Sep; 356(9):1405-12. PubMed ID: 1100508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor.
    Kurose T; Pashmforoush M; Yoshimasa Y; Carroll R; Schwartz GP; Burke GT; Katsoyannis PG; Steiner DF
    J Biol Chem; 1994 Nov; 269(46):29190-7. PubMed ID: 7961885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.